id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2257-0004,FDA,FDA-2020-E-2257,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2021-10-12T04:00:00Z,2021,10,2021-10-12T04:00:00Z,,2021-10-12T18:19:41Z,,0,0,0900006484dc2b3d
FDA-2020-E-2257-0003,FDA,FDA-2020-E-2257,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-04-05T04:00:00Z,2021,4,2021-04-05T04:00:00Z,,2021-04-05T19:39:40Z,,0,0,0900006484a9acc7